• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DKN
Click for more information
0.00% 79.5¢

DKN FINANCIAL GROUP LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DKN
Ann: Removal from official list 		20/10/11 0 1.0K
20/10/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.0K 
DKN +
Ann: Scheme Implementation - Changes to the Board 		17/10/11 0 916
17/10/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  916 
DKN
Ann: Appendix 3B 		07/10/11 0 749
Metals & Mining SECTOR NEWS

Second round assay results shapes promising greenfields gold discovery at Claw Gold Project

Read More   right-arrow Created with Sketch.
BPM
20 Sep 2024
BPM MINERALS LIMITED
07/10/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  749 
DKN
Ann: Suspension from Official Quotation 		04/10/11 0 814
04/10/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  814 
DKN +
Ann: Scheme Becomes Effective 		04/10/11 0 877
04/10/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  877 
DKN +
Ann: Scheme Court Approval 		03/10/11 0 677
03/10/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  677 
DKN +
Ann: Results of Meeting 		27/09/11 0 749
27/09/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  749 
DKN
Ann: Becoming a substantial holder 		14/09/11 0 637
14/09/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  637 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.

Top Stories

ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024

Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.

Featured News

NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.